Migden M, Rischin D, Sasane M, Mastey V, Pavlick A, Schmults C, Chen Z, Guminski A, Hauschild A, Bury D, Hudgens S, Chang AL, Rabinowits G, Ibrahim S, Fury M, Lowy I, Li S, Chen C-I. Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial. J of Skin [Internet]. 2021Jan.1 [cited 2024Jul.3];5(1):s5. Available from: https://jofskin.org/index.php/skin/article/view/1157